Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cofavin DM is a sugar-free polyherbal Ayurvedic formulation developed by AVN Ayurveda Pharmaceuticals for the treatment of cough and upper respiratory tract infections. It is specifically designed for both diabetic and non-diabetic patients. The formulation contains aqueous extracts of several medicinal herbs, including *Adhatoda vasika*, *Ocimum sanctum*, *Glycyrrhiza glabra*, *Abies webbiana*, and *trikatu*. These ingredients provide a multi-faceted therapeutic approach, acting as an expectorant, bronchodilator, mucolytic, decongestant, and demulcent to relieve cough and associated respiratory difficulties. As an Ayurvedic medicine, it follows the AYUSH regulatory framework in India and is marketed for its fast relief from cough without side effects.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cofavin DM.